Zobrazeno 1 - 10
of 10
pro vyhledávání: '"K U Kiran"'
Publikováno v:
Radiation Protection and Environment, Vol 42, Iss 4, Pp 180-186 (2019)
An attempt has been made to prepare the nonlead-based gamma shielding materials by adding different weight percentages (0%, 10%, 20%, and 40%) of bismuth in high-density polyethylene (HDPE) matrix. Gamma shielding parameters such as linear attenuatio
Externí odkaz:
https://doaj.org/article/9bf811ae00e7422e8433b985af5a4648
Publikováno v:
Microwave and Optical Technology Letters. 49:2022-2026
In this paper, compact L-shaped notched printed antennas with dual slits for multiband and wideband applications are presented. Here, an L-shaped notch is cut on one side of the nonradiating edge of the rectangular patch with dual narrow slits cut on
Publikováno v:
Indian journal of dermatology, venereology and leprology. 75(2)
Lymphadenopathy is known to be associated with lepromatous leprosy and has also been observed as a feature of type-2 lepra reaction. However, nodular lymph node enlargement is not commonly reported in leprosy patients or as a feature of relapse. We h
Publikováno v:
Scopus-Elsevier
In this paper, a novel compact broadband dual frequency microstrip antenna is presented. The proposed design consists of a rectangular microstrip antenna with a pair of parallel slots loaded close to the radiating edge of the patch and three meanderi
Treatment of recent facial nerve damage with lagophthalmos, using a semistandardized steroid regimen
Publikováno v:
Leprosy review. 62(2)
Twenty-seven patients with borderline leprosy and facial nerve damage of less than or equal to 6 months duration (36 eyes) were treated with a semistandardized regimen of steroids (the average starting dose was 25-30 mg, duration 5-6 months) on an ou
Publikováno v:
Leprosy Review. 62
Charts of 1226 paucibacillary leprosy patients, registered between 1982 and 1987 were reviewed for recent facial nerve damage, facial patches and the presence of Type I reaction. Twenty-six (2.1%) patients with recent lagophthalmos were identified. I
Publikováno v:
Leprosy review. 57(1)
Publikováno v:
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 52(4)
Publikováno v:
Leprosy Review. 56
33 patients atteints de lepre borderline chez qui est apparue une alteration des fonctions nerveuses sont traites par un traitement semi-standardise de corticoides: dose initiale moyenne de 25 mg, pendant 5 mois en moyenne. On observe une amelioratio
Publikováno v:
Leprosy Review. 59
On conclut que le prothionamide est utilise en traitement alternatif du clofazimine dans un traitement associe de la lepre lepromateuse